BridgeBio Pharma, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BBIO Nasdaq 2836 bridgebio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BridgeBio Pharma, Inc.

BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026 - Nov 3rd, 2026 5:30 am
Recursion Appoints Fred Hassan as Chair of the Board - Nov 2nd, 2026 2:05 pm
Should You Invest $1,000 in BridgeBio Pharma Right Now? - Nov 2nd, 2026 5:05 am
What Is BridgeBio Pharma (BBIO) Betting On With Three FDA Priority Launches? - Nov 1st, 2026 2:10 pm
BridgeBio's Heart Disorder Drug Attruby Faces Unanticipated Near-Term Tailwinds, UBS Says - Oct 30th, 2026 11:04 am
BridgeBio (BBIO) Q3 2026 Earnings Call Transcript - Oct 30th, 2026 8:29 am
BridgeBio Pharma, Inc. Q3 2026 Earnings Call Summary - Oct 30th, 2026 6:30 am
What BridgeBio Pharma (BBIO) Said on Its Q3 Earnings Call - Oct 29th, 2026 6:14 pm
BridgeBio Pharma (BBIO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Oct 29th, 2026 2:30 pm
BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates - Oct 29th, 2026 2:10 pm
BridgeBio Pharma: Q3 Earnings Snapshot - Oct 29th, 2026 2:07 pm
BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates - Oct 29th, 2026 2:01 pm
Alnylam Sinks 19% as It Expands Nucresiran Heart Trial Again, Citing “A High Level of Conviction” - Oct 29th, 2026 10:04 am
BridgeBio to Report Third Quarter 2026 Financial Results and Commercial Updates on October 29, 2026 at 4:30 pm ET - Oct 22nd, 2026 5:30 am
The Zacks Analyst Blog Highlights BridgeBio Pharma, Intellia Therapeutics, Biogen and Viking Therapeutics - Oct 21st, 2026 6:06 am
What BridgeBio Pharma Doubters Missed - Oct 20th, 2026 9:12 am
4 Biotech Stocks With Promising Late-Stage Drug Pipelines to Watch Now - Oct 20th, 2026 7:30 am
BridgeBio Pharma (BBIO) Draws Fresh Attention, Is The Pullback A Valuation Opportunity? - Oct 20th, 2026 5:15 am
Where Does BridgeBio Pharma (BBIO) Value Sit After Trial Wins? - Oct 20th, 2026 4:11 am